Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02045108 · ClinicalTrials.gov registry record · NA
Cognitive Retraining and Brain Stimulation for Alcohol Use
A NA study, sponsored by The Mind Research Network.
- Completed
- Registry status
- NA
- Development phase
- 77
- Enrollment target
NCT02045108: Completed NA study, sponsored by The Mind Research Network.
NCT02045108 is a NA study that has completed, run by The Mind Research Network. The registered enrollment target is 77 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02045108, a NA study, has completed, sponsored by The Mind Research Network.
- COMPLETED
- Registry status
- NA
- Development phase
- 77 participants
- Enrollment target
Study Summary
The overarching goal of this study is to determine whether combined cognitive training and Transcranial Direct Current Stimulation (tDCS) reduces drinking in high-risk drinkers. To this end, specific study purposes are: 1) replicate previous findings that cognitive retraining reduces drinking levels, 2) test whether cognitive retraining can be enhanced with tDCS, and 3) investigate the neural changes that result from cognitive retraining and tDCS. We hypothesize that those participants who receive alcohol avoidance cognitive training will have greater reductions in drinking. In turn, those participants who receive a higher level of applied tDCS during alcohol avoidance response training will have better avoidance learning, as well as, a larger reduction in drinking behavior. Finally, those participants receiving a higher level of applied tDCS will have more neuronal response associated with alcohol avoidance during the brain imaging session.
Primary Outcome
Number of standard drinks will be assessed using the Timeline Follow-back method to obtain the number of drinks consumed on each day of the prior 30 days. Drinks per drinking day will be the mean number of drinks consumed on days on which alcohol was consumed.
Interventions
- BEHAVIORAL Active Retraining
- BEHAVIORAL Sham Retraining
- DEVICE Sham TDCS
- DEVICE Active TDCS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2014-01 |
| Est. Completion | 2015-12 |
| Phase | NA |
What the finished NCT02045108 record still lists
NCT02045108 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 4 interventions - of which Active Retraining is the first listed.
NCT02045108 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02045108 about?
NCT02045108 is a clinical study titled "Cognitive Retraining and Brain Stimulation for Alcohol Use". The overarching goal of this study is to determine whether combined cognitive training and Transcranial Direct Current Stimulation (tDCS) reduces drinking in high-risk drinkers. To this end, specific study purposes are: 1) replicate previous findings that cognitive retraining reduces drinking levels...
What is the current status of trial NCT02045108?
This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2014-01. Estimated completion is 2015-12.
What interventions are being tested in trial NCT02045108?
The interventions under investigation include: Active Retraining (BEHAVIORAL), Sham Retraining (BEHAVIORAL), Sham TDCS (DEVICE), Active TDCS (DEVICE).
Who is sponsoring clinical trial NCT02045108?
This trial is sponsored by The Mind Research Network, which has 17 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02045108's enrollment target sits among peer trials
77 1062nd of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02127398 · 77 participants · Phase 2
Stool Transplants to Treat Refractory Clostridium Difficile Colitis
- NCT04159103 · 77 participants · Phase 1
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
- NCT04683003 · 77 participants · Phase 3
A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura
- NCT05004116 · 77 participants · Phase 1
A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia